Astral Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: July 3, 2025, 1:17 pm

Market Cap	40,134 Cr.
Current Price	1,494
High / Low	2,433/1,232
Stock P/E	77.3
Book Value	135
Dividend Yield	0.25 %
ROCE	20.3 %
ROE	15.2 %
Face Value	1.00
PEG Ratio	14.73

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Astral Ltd

Competitors of Astral Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Dutron Polymers Ltd	80.0 Cr.	133	207/110	29.4	48.6	1.12 %	12.4 %	9.79 %	10.0
Captain Polyplast Ltd	464 Cr.	77.8	128/51.5	25.8	25.5	0.00 %	16.0 %	15.0 %	2.00
Captain Pipes Ltd	231 Cr.	15.0	21.0/13.0	52.3	2.58	0.00 %	17.0 %	13.5 %	1.00
Caprihans India Ltd	192 Cr.	132	195/114		296	0.00 %	0.78 %	15.2 %	10.0
Ashish Polyplast Ltd	12.5 Cr.	36.8	95.4/30.0	50.1	19.8	0.00 %	6.84 %	3.79 %	10.0
Industry Average	6,019.50 Cr	244.09		46.04	87.41	0.18%	10.58%	10.39%	8.00

All Competitor Stocks of Astral Ltd

Quarterly Result

Metric	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	1,391	1,213	1,172	1,268	1,506	1,283	1,363	1,370	1,625	1,384	1,370	1,397	1,681
Expenses	1,176	1,042	1,028	1,081	1,199	1,082	1,143	1,165	1,334	1,169	1,160	1,178	1,380
Operating Profit	215	171	144	186	307	202	220	205	291	214	210	219	302
OPM %	15%	14%	12%	15%	20%	16%	16%	15%	18%	16%	15%	16%	18%
Other Income	16	14	14	-2	12	12	13	6	10	12	9	12	9
Interest	5	13	14	9	3	6	8	8	8	8	10	14	10
Depreciation	33	43	45	46	44	46	49	50	52	56	60	63	65
Profit before tax	193	128	99	130	272	162	177	154	241	163	149	154	236
Tax %	25%	25%	24%	27%	24%	26%	26%	26%	25%	27%	27%	27%	25%
Net Profit	144	96	75	95	206	119	132	113	181	120	109	113	178
EPS in Rs	5.28	3.32	2.57	3.46	7.66	4.46	4.88	4.23	6.76	4.48	4.09	4.25	6.67

Last Updated: May 31, 2025, 9:46 am

Below is a detailed analysis of the quarterly data for Astral Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Sales, as of Mar 2025, the value is 1,681.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,397.00 Cr. (Dec 2024) to 1,681.00 Cr., marking an increase of 284.00 Cr..
For Expenses, as of Mar 2025, the value is 1,380.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,178.00 Cr. (Dec 2024) to 1,380.00 Cr., marking an increase of 202.00 Cr..
For Operating Profit, as of Mar 2025, the value is 302.00 Cr.. The value appears strong and on an upward trend. It has increased from 219.00 Cr. (Dec 2024) to 302.00 Cr., marking an increase of 83.00 Cr..
For OPM %, as of Mar 2025, the value is 18.00%. The value appears strong and on an upward trend. It has increased from 16.00% (Dec 2024) to 18.00%, marking an increase of 2.00%.
For Other Income, as of Mar 2025, the value is 9.00 Cr.. The value appears to be declining and may need further review. It has decreased from 12.00 Cr. (Dec 2024) to 9.00 Cr., marking a decrease of 3.00 Cr..
For Interest, as of Mar 2025, the value is 10.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 14.00 Cr. (Dec 2024) to 10.00 Cr., marking a decrease of 4.00 Cr..
For Depreciation, as of Mar 2025, the value is 65.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 63.00 Cr. (Dec 2024) to 65.00 Cr., marking an increase of 2.00 Cr..
For Profit before tax, as of Mar 2025, the value is 236.00 Cr.. The value appears strong and on an upward trend. It has increased from 154.00 Cr. (Dec 2024) to 236.00 Cr., marking an increase of 82.00 Cr..
For Tax %, as of Mar 2025, the value is 25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Dec 2024) to 25.00%, marking a decrease of 2.00%.
For Net Profit, as of Mar 2025, the value is 178.00 Cr.. The value appears strong and on an upward trend. It has increased from 113.00 Cr. (Dec 2024) to 178.00 Cr., marking an increase of 65.00 Cr..
For EPS in Rs, as of Mar 2025, the value is 6.67. The value appears strong and on an upward trend. It has increased from 4.25 (Dec 2024) to 6.67, marking an increase of 2.42.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 6:04 pm

Metric	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	1,057	1,410	1,678	1,895	2,073	2,507	2,578	3,176	4,394	5,158	5,641	5,832
Expenses	902	1,242	1,470	1,633	1,759	2,126	2,136	2,539	3,640	4,349	4,717	4,886
Operating Profit	155	168	208	261	314	382	442	638	754	810	925	946
OPM %	15%	12%	12%	14%	15%	15%	17%	20%	17%	16%	16%	16%
Other Income	2	3	-4	8	13	15	11	25	35	37	36	41
Interest	31	25	30	18	22	32	39	13	13	40	29	41
Depreciation	22	36	42	50	57	81	108	116	127	178	198	243
Profit before tax	105	110	132	201	248	283	306	533	648	628	734	702
Tax %	24%	29%	22%	28%	29%	30%	18%	23%	24%	25%	26%	26%
Net Profit	79	78	102	145	176	197	250	408	490	472	546	519
EPS in Rs	1.26	2.89	3.79	5.44	6.58	7.36	9.25	15.10	18.06	17.00	20.33	19.50
Dividend Payout %	5%	6%	5%	5%	4%	4%	6%	10%	12%	21%	18%	19%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	-1.27%	30.77%	42.16%	21.38%	11.93%	26.90%	63.20%	20.10%	-3.67%	15.68%	-4.95%
Change in YoY Net Profit Growth (%)	0.00%	32.04%	11.39%	-20.78%	-9.45%	14.97%	36.30%	-43.10%	-23.77%	19.35%	-20.62%

Astral Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	15%
5 Years:	18%
3 Years:	10%
TTM:	3%

Compounded Profit Growth
10 Years:	21%
5 Years:	16%
3 Years:	3%
TTM:	-3%

Stock Price CAGR
10 Years:	24%
5 Years:	22%
3 Years:	5%
1 Year:	-37%

Return on Equity
10 Years:	18%
5 Years:	19%
3 Years:	17%
Last Year:	15%

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 12:27 pm

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	11	12	12	12	12	12	15	20	20	27	27	27
Reserves	304	607	696	835	1,006	1,266	1,488	1,876	2,316	2,684	3,161	3,590
Borrowings	142	203	197	229	189	275	191	80	98	87	119	233
Other Liabilities	237	344	397	386	468	546	595	697	952	1,564	1,188	1,206
Total Liabilities	694	1,165	1,301	1,462	1,675	2,099	2,289	2,673	3,387	4,362	4,496	5,056
Fixed Assets	289	557	645	741	842	1,105	1,255	1,314	1,496	1,950	2,299	2,712
CWIP	8	27	15	25	73	81	44	57	123	126	151	116
Investments	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	397	582	641	695	759	913	990	1,302	1,768	2,286	2,046	2,228
Total Assets	694	1,165	1,301	1,462	1,675	2,099	2,289	2,673	3,387	4,362	4,496	5,056

Below is a detailed analysis of the balance sheet data for Astral Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Equity Capital, as of Mar 2025, the value is 27.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 27.00 Cr..
For Reserves, as of Mar 2025, the value is 3,590.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,161.00 Cr. (Mar 2024) to 3,590.00 Cr., marking an increase of 429.00 Cr..
For Borrowings, as of Mar 2025, the value is 233.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 119.00 Cr. (Mar 2024) to 233.00 Cr., marking an increase of 114.00 Cr..
For Other Liabilities, as of Mar 2025, the value is 1,206.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,188.00 Cr. (Mar 2024) to 1,206.00 Cr., marking an increase of 18.00 Cr..
For Total Liabilities, as of Mar 2025, the value is 5,056.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,496.00 Cr. (Mar 2024) to 5,056.00 Cr., marking an increase of 560.00 Cr..
For Fixed Assets, as of Mar 2025, the value is 2,712.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,299.00 Cr. (Mar 2024) to 2,712.00 Cr., marking an increase of 413.00 Cr..
For CWIP, as of Mar 2025, the value is 116.00 Cr.. The value appears to be declining and may need further review. It has decreased from 151.00 Cr. (Mar 2024) to 116.00 Cr., marking a decrease of 35.00 Cr..
For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
For Other Assets, as of Mar 2025, the value is 2,228.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,046.00 Cr. (Mar 2024) to 2,228.00 Cr., marking an increase of 182.00 Cr..
For Total Assets, as of Mar 2025, the value is 5,056.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,496.00 Cr. (Mar 2024) to 5,056.00 Cr., marking an increase of 560.00 Cr..

Notably, the Reserves (3,590.00 Cr.) exceed the Borrowings (233.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Month		Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Cash from Operating Activity +	67	117	226	114	282	342	405	664	543	557	823	630
Cash from Investing Activity +	-91	-343	-203	-158	-185	-291	-318	-454	72	-478	-541	-513
Cash from Financing Activity +	13	237	16	12	-71	-5	-163	-153	-44	-191	-202	-118
Net Cash Flow	-11	11	38	-32	25	46	-75	57	571	-112	80	-1

Free Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	13.00	-35.00	11.00	32.00	125.00	107.00	251.00	558.00	656.00	723.00	806.00	713.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	48	50	60	49	65	54	49	32	32	22	25	24
Inventory Days	95	92	92	84	76	94	88	124	88	91	96	100
Days Payable	107	87	93	96	80	92	86	109	96	93	88	95
Cash Conversion Cycle	36	55	60	38	61	56	51	47	23	20	33	29
Working Capital Days	31	56	64	30	47	38	32	42	18	18	20	21
ROCE %	32%	34%	21%	18%	22%	23%	23%	21%	29%	29%	24%	23%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	55.73%	55.73%	55.85%	55.85%	55.85%	55.85%	55.85%	54.10%	54.10%	54.10%	54.10%	54.10%
FIIs	17.79%	16.07%	16.26%	14.88%	13.86%	15.65%	18.50%	19.79%	21.22%	22.48%	22.32%	21.07%
DIIs	12.70%	13.60%	14.37%	15.23%	16.50%	15.87%	13.21%	13.66%	12.85%	12.45%	12.48%	13.76%
Government	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.15%
Public	13.78%	14.60%	13.53%	14.04%	13.79%	12.64%	12.44%	12.44%	11.81%	10.96%	11.11%	10.90%
No. of Shareholders	2,41,931	2,72,680	2,70,045	3,03,281	3,19,899	2,92,672	2,95,456	2,93,602	2,85,688	2,62,050	2,93,911	2,97,527

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
Axis ELSS Tax Saver Fund	3,518,753	2.09	745.31	3,518,753	2025-04-22 17:25:41	0%
UTI Flexi Cap Fund	3,172,930	2.77	672.06	3,172,930	2025-04-22 17:25:41	0%
Axis Midcap Fund	2,909,916	2.31	616.35	2,909,916	2025-04-22 17:25:41	0%
Nippon India Growth Fund	1,903,149	1.5	403.11	1,903,149	2025-04-22 17:25:41	0%
UTI Mid Cap Fund	956,190	1.93	202.53	956,190	2025-04-22 17:25:41	0%
PGIM India Midcap Opportunities Fund	749,000	1.56	158.65	749,000	2025-04-22 17:25:41	0%
Axis Growth Opportunities Fund	622,415	1.09	131.83	622,415	2025-04-22 17:25:41	0%
Axis Flexi Cap Fund	584,696	1.03	123.84	584,696	2025-04-22 17:25:41	0%
Sundaram Mid Cap Fund	505,581	1	107.09	505,581	2025-04-22 17:25:41	0%
Sundaram Mid Cap Fund - Institutional Plan	505,581	1	107.09	505,581	2025-04-22 17:25:41	0%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	1.00	1.00	1.00	1.00	1.00
Basic EPS (Rs.)	20.33	17.00	24.08	20.13	16.45
Diluted EPS (Rs.)	20.33	17.00	24.08	20.13	16.45
Cash EPS (Rs.)	27.63	24.24	30.81	26.45	23.78
Book Value[Excl.RevalReserv]/Share (Rs.)	121.46	109.95	117.57	95.31	100.56
Book Value[Incl.RevalReserv]/Share (Rs.)	121.51	110.00	117.63	95.37	100.64
Revenue From Operations / Share (Rs.)	209.72	191.77	218.61	158.02	170.72
PBDIT / Share (Rs.)	35.70	31.10	39.31	33.31	30.13
PBIT / Share (Rs.)	28.36	24.48	33.00	27.52	22.99
PBT / Share (Rs.)	27.27	22.93	32.36	26.87	20.38
Net Profit / Share (Rs.)	20.29	17.62	24.49	20.66	16.64
NP After MI And SOA / Share (Rs.)	20.30	16.97	24.07	20.12	16.42
PBDIT Margin (%)	17.02	16.21	17.98	21.08	17.65
PBIT Margin (%)	13.52	12.76	15.09	17.41	13.46
PBT Margin (%)	13.00	11.95	14.80	17.00	11.93
Net Profit Margin (%)	9.67	9.18	11.20	13.07	9.74
NP After MI And SOA Margin (%)	9.68	8.85	11.01	12.73	9.61
Return on Networth / Equity (%)	17.13	16.84	20.71	21.34	16.50
Return on Capital Employeed (%)	22.59	21.66	27.11	27.87	20.72
Return On Assets (%)	12.14	10.44	14.28	15.13	10.82
Long Term Debt / Equity (X)	0.01	0.01	0.01	0.01	0.07
Total Debt / Equity (X)	0.03	0.02	0.03	0.02	0.08
Asset Turnover Ratio (%)	1.27	1.32	1.27	1.10	1.01
Current Ratio (X)	1.77	1.69	1.85	1.84	1.57
Quick Ratio (X)	0.95	1.03	1.08	1.16	0.68
Inventory Turnover Ratio (X)	3.89	3.99	4.59	3.23	3.15
Dividend Payout Ratio (NP) (%)	18.43	13.20	9.34	3.73	9.68
Dividend Payout Ratio (CP) (%)	13.54	9.50	7.40	2.89	6.74
Earning Retention Ratio (%)	81.57	86.80	90.66	96.27	90.32
Cash Earning Retention Ratio (%)	86.46	90.50	92.60	97.11	93.26
Interest Coverage Ratio (X)	33.00	20.91	61.26	51.11	11.55
Interest Coverage Ratio (Post Tax) (X)	19.75	12.57	39.16	32.69	7.38
Enterprise Value (Cr.)	53110.31	35606.86	40137.42	32080.57	13972.90
EV / Net Operating Revenue (X)	9.41	6.90	9.13	10.10	5.42
EV / EBITDA (X)	55.30	42.56	50.79	47.91	30.71
MarketCap / Net Operating Revenue (X)	9.49	6.97	9.25	10.23	5.41
Retention Ratios (%)	81.56	86.79	90.65	96.26	90.31
Price / BV (X)	16.80	13.27	17.41	17.15	9.30
Price / Net Operating Revenue (X)	9.49	6.97	9.25	10.23	5.41
EarningsYield	0.01	0.01	0.01	0.01	0.01

After reviewing the key financial ratios for Astral Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
For Basic EPS (Rs.), as of Mar 24, the value is 20.33. This value is within the healthy range. It has increased from 17.00 (Mar 23) to 20.33, marking an increase of 3.33.
For Diluted EPS (Rs.), as of Mar 24, the value is 20.33. This value is within the healthy range. It has increased from 17.00 (Mar 23) to 20.33, marking an increase of 3.33.
For Cash EPS (Rs.), as of Mar 24, the value is 27.63. This value is within the healthy range. It has increased from 24.24 (Mar 23) to 27.63, marking an increase of 3.39.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 121.46. It has increased from 109.95 (Mar 23) to 121.46, marking an increase of 11.51.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 121.51. It has increased from 110.00 (Mar 23) to 121.51, marking an increase of 11.51.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 209.72. It has increased from 191.77 (Mar 23) to 209.72, marking an increase of 17.95.
For PBDIT / Share (Rs.), as of Mar 24, the value is 35.70. This value is within the healthy range. It has increased from 31.10 (Mar 23) to 35.70, marking an increase of 4.60.
For PBIT / Share (Rs.), as of Mar 24, the value is 28.36. This value is within the healthy range. It has increased from 24.48 (Mar 23) to 28.36, marking an increase of 3.88.
For PBT / Share (Rs.), as of Mar 24, the value is 27.27. This value is within the healthy range. It has increased from 22.93 (Mar 23) to 27.27, marking an increase of 4.34.
For Net Profit / Share (Rs.), as of Mar 24, the value is 20.29. This value is within the healthy range. It has increased from 17.62 (Mar 23) to 20.29, marking an increase of 2.67.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 20.30. This value is within the healthy range. It has increased from 16.97 (Mar 23) to 20.30, marking an increase of 3.33.
For PBDIT Margin (%), as of Mar 24, the value is 17.02. This value is within the healthy range. It has increased from 16.21 (Mar 23) to 17.02, marking an increase of 0.81.
For PBIT Margin (%), as of Mar 24, the value is 13.52. This value is within the healthy range. It has increased from 12.76 (Mar 23) to 13.52, marking an increase of 0.76.
For PBT Margin (%), as of Mar 24, the value is 13.00. This value is within the healthy range. It has increased from 11.95 (Mar 23) to 13.00, marking an increase of 1.05.
For Net Profit Margin (%), as of Mar 24, the value is 9.67. This value is within the healthy range. It has increased from 9.18 (Mar 23) to 9.67, marking an increase of 0.49.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 9.68. This value is within the healthy range. It has increased from 8.85 (Mar 23) to 9.68, marking an increase of 0.83.
For Return on Networth / Equity (%), as of Mar 24, the value is 17.13. This value is within the healthy range. It has increased from 16.84 (Mar 23) to 17.13, marking an increase of 0.29.
For Return on Capital Employeed (%), as of Mar 24, the value is 22.59. This value is within the healthy range. It has increased from 21.66 (Mar 23) to 22.59, marking an increase of 0.93.
For Return On Assets (%), as of Mar 24, the value is 12.14. This value is within the healthy range. It has increased from 10.44 (Mar 23) to 12.14, marking an increase of 1.70.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.01.
For Total Debt / Equity (X), as of Mar 24, the value is 0.03. This value is within the healthy range. It has increased from 0.02 (Mar 23) to 0.03, marking an increase of 0.01.
For Asset Turnover Ratio (%), as of Mar 24, the value is 1.27. It has decreased from 1.32 (Mar 23) to 1.27, marking a decrease of 0.05.
For Current Ratio (X), as of Mar 24, the value is 1.77. This value is within the healthy range. It has increased from 1.69 (Mar 23) to 1.77, marking an increase of 0.08.
For Quick Ratio (X), as of Mar 24, the value is 0.95. This value is below the healthy minimum of 1. It has decreased from 1.03 (Mar 23) to 0.95, marking a decrease of 0.08.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 3.89. This value is below the healthy minimum of 4. It has decreased from 3.99 (Mar 23) to 3.89, marking a decrease of 0.10.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 18.43. This value is below the healthy minimum of 20. It has increased from 13.20 (Mar 23) to 18.43, marking an increase of 5.23.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 13.54. This value is below the healthy minimum of 20. It has increased from 9.50 (Mar 23) to 13.54, marking an increase of 4.04.
For Earning Retention Ratio (%), as of Mar 24, the value is 81.57. This value exceeds the healthy maximum of 70. It has decreased from 86.80 (Mar 23) to 81.57, marking a decrease of 5.23.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 86.46. This value exceeds the healthy maximum of 70. It has decreased from 90.50 (Mar 23) to 86.46, marking a decrease of 4.04.
For Interest Coverage Ratio (X), as of Mar 24, the value is 33.00. This value is within the healthy range. It has increased from 20.91 (Mar 23) to 33.00, marking an increase of 12.09.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 19.75. This value is within the healthy range. It has increased from 12.57 (Mar 23) to 19.75, marking an increase of 7.18.
For Enterprise Value (Cr.), as of Mar 24, the value is 53,110.31. It has increased from 35,606.86 (Mar 23) to 53,110.31, marking an increase of 17,503.45.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 9.41. This value exceeds the healthy maximum of 3. It has increased from 6.90 (Mar 23) to 9.41, marking an increase of 2.51.
For EV / EBITDA (X), as of Mar 24, the value is 55.30. This value exceeds the healthy maximum of 15. It has increased from 42.56 (Mar 23) to 55.30, marking an increase of 12.74.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 9.49. This value exceeds the healthy maximum of 3. It has increased from 6.97 (Mar 23) to 9.49, marking an increase of 2.52.
For Retention Ratios (%), as of Mar 24, the value is 81.56. This value exceeds the healthy maximum of 70. It has decreased from 86.79 (Mar 23) to 81.56, marking a decrease of 5.23.
For Price / BV (X), as of Mar 24, the value is 16.80. This value exceeds the healthy maximum of 3. It has increased from 13.27 (Mar 23) to 16.80, marking an increase of 3.53.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 9.49. This value exceeds the healthy maximum of 3. It has increased from 6.97 (Mar 23) to 9.49, marking an increase of 2.52.
For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Astral Ltd as of July 4, 2025 is: 1,272.13

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of July 4, 2025, Astral Ltd is Overvalued by 14.85% compared to the current share price 1,494.00

Intrinsic Value of Astral Ltd as of July 4, 2025 is: 1,338.88

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of July 4, 2025, Astral Ltd is Overvalued by 10.38% compared to the current share price 1,494.00

Last 5 Year EPS CAGR: 5.25%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 24.92%, which is a positive sign. The company has higher reserves (1,652.42 cr) compared to borrowings (170.25 cr), indicating strong financial stability. The company has shown consistent growth in sales (2.67 cr) and profit (385.83 cr) over the years.	The stock has a high average Working Capital Days of 34.75, which may not be favorable. The stock has a high average Cash Conversion Cycle of 42.42, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Astral Ltd:
1. Net Profit Margin: 9.67%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 22.59% (Industry Average ROCE: 10.58%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 17.13% (Industry Average ROE: 10.39%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 19.75
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 0.95
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 77.3 (Industry average Stock P/E: 46.04)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.03
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Astral Ltd. is a Public Limited Listed company incorporated on 25/03/1996 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L25200GJ1996PLC029134 and registration number is 029134. Currently Company is involved in the business activities of Manufacture of plastics products. Company's Total Operating Revenue is Rs. 5295.90 Cr. and Equity Capital is Rs. 26.90 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Plastics - Pipes & Fittings	Astral House 207/1, B/h. Rajpath Club, Ahmedabad Gujarat 380059	info@astralpipes.com http://www.astralltd.com

Management
Name	Position Held
Mr. Sandeep P Engineer	Chairman & Managing Director
Mrs. Jagruti S Engineer	Whole Time Director
Mr. Girish B Joshi	Whole Time Director
Mrs. Kaushal D Nakrani	Independent Director
Mr. Viral M Jhaveri	Independent Director
Mr. C K Gopal	Independent Director
Mr. Chetas Desai	Independent Director
Mr. Dhinal Shah	Independent Director
Mr. Kairav Engineer	Whole Time Director
Mr. Hiranand Savlani	Whole Time Director

FAQ

What is the intrinsic value of Astral Ltd?

Astral Ltd's intrinsic value (as of 04 July 2025) is 1272.13 — 14.85% lower the current market price of 1,494.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 40,134 Cr. market cap, FY2025-2026 high/low of 2,433/1,232, reserves of 3,590 Cr, and liabilities of 5,056 Cr.

What is the Market Cap of Astral Ltd?

The Market Cap of Astral Ltd is 40,134 Cr..

What is the current Stock Price of Astral Ltd as on 04 July 2025?

The current stock price of Astral Ltd as on 04 July 2025 is 1,494.

What is the High / Low of Astral Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Astral Ltd stocks is ₹2,433/1,232.

What is the Stock P/E of Astral Ltd?

The Stock P/E of Astral Ltd is 77.3.

What is the Book Value of Astral Ltd?

The Book Value of Astral Ltd is 135.

What is the Dividend Yield of Astral Ltd?

The Dividend Yield of Astral Ltd is 0.25 %.

What is the ROCE of Astral Ltd?

The ROCE of Astral Ltd is 20.3 %.

What is the ROE of Astral Ltd?

The ROE of Astral Ltd is 15.2 %.

What is the Face Value of Astral Ltd?

The Face Value of Astral Ltd is 1.00.